Ikarian Capital, LLC - SEELOS THERAPEUTICS INC ownership

SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 93 filers reported holding SEELOS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.

Quarter-by-quarter ownership
Ikarian Capital, LLC ownership history of SEELOS THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$215,000
-46.0%
257,883
+5.6%
0.03%
-52.5%
Q4 2021$398,000
-32.4%
244,1710.0%0.06%
+43.9%
Q3 2021$589,000
-20.3%
244,171
-12.7%
0.04%
-31.7%
Q2 2021$739,000
-79.4%
279,840
-61.0%
0.06%
-50.4%
Q1 2021$3,585,000718,2840.12%
Other shareholders
SEELOS THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
GENDELL JEFFREY L 4,933,024$4,133,0000.30%
ACUTA CAPITAL PARTNERS, LLC 295,896$248,0000.12%
Connacht Asset Management LP 231,551$194,0000.10%
Uniplan Investment Counsel, Inc. 1,564,605$1,310,0000.08%
AdvisorShares Investments LLC 358,796$301,0000.05%
1492 Capital Management LLC 99,819$84,0000.04%
Woodline Partners LP 2,803,230$2,349,0000.04%
Ikarian Capital, LLC 257,883$215,0000.03%
Sovereign Financial Group, Inc. 75,000$63,0000.02%
Aquatic Capital Management LLC 6,400$5,0000.01%
View complete list of SEELOS THERAPEUTICS INC shareholders